2007Modern Medicine HealthRequires access

Effects of isoflurane delayed preconditioning on Bcl-2 protein expression and IL-10 level in ischemiareperfusion myocardium of rabbit

Dingquan Zou

Open publisher page 0 citations

Abstract

Objective:To investigate the protective effect of isoflurane delayed preconditioning on myocardial ischemia reperfusion injury and the potential mechanisms in rabbit. Methods:Thirty New Zealand male white rabbits were randomly assigned to 3 groups:(1)Control group;(2)I/R group;(3)2.0% isoflurane group. Group 3 was exposed to 2.0% isoflurane-100% oxygen for 2 h. Group 1 and group 2 were exposed 2 h to 100% oxygen serving as untreated controls. Twenty-four hours later group 2 and group 3 underwent 40 min of coronary occlusion followed by 2 h of reperfusion. Blood samples were taken from arterial line at 20min before occlusion(T1)、20min after occlusion(T2)、40min after occlusion(T3)、1h after reperfusion(T4) and 2h after reperfusion(T5) for determination of the plasma level of IL-10. At the end of the reperfusion, infarct size(IS) and area at risk(AAR) were defined by Evans and TTC staining. The heart was harvested and level of the Bcl-2 expression was determined by Western Blot analysis. Results: The Bcl-2 level of group 3 was significantly higher than that of group 2(P0.05). Isoflurane significantly(P0.05) reduced infarct size(19.7%±2.8% in group 3) of the left ventricular area at risk as compared with control group (37.8%±1.7% in group 2). Group 3 had a higher levels of IL-10 than that of Group 2. Conclusion: Isoflurane can promote Bcl-2 expression and increase the IL-10 level during ischemia reperfusion, which may be one of molecular mechanisms of isoflurane delayed preconditioning on cardioprotection.

About this research paper

What this paper is about

Objective:To investigate the protective effect of isoflurane delayed preconditioning on myocardial ischemia reperfusion injury and the potential mechanisms in rabbit. Methods:Thirty New Zealand male white rabbits were randomly assigned to 3 groups:(1)Control group;(2)I/R group;(3)2.0% isoflurane group. Group 3 was exposed to 2.0% isoflurane-100% oxygen for 2 h. Group 1 and group 2 were exposed 2 h to 100% oxygen serving as untreated controls. Twenty-four hours later group 2 and group 3 underwent 40 min of coronary occlusion followed by 2 h of reperfusion. Blood samples were taken from arterial line at 20min before occlusion(T1)、20min after occlusion(T2)、40min after occlusion(T3)、1h after reperfusion(T4) and 2h after reperfusion(T5) for determination of the plasma level of IL-10. At the end of the reperfusion, infarct size(IS) and area at risk(AAR) were defined by Evans and TTC staining. The heart was harvested and level of the Bcl-2 expression was determined by Western Blot analysis. Results: The Bcl-2 level of group 3 was significantly higher than that of group 2(P0.05). Isoflurane significantly(P0.05) reduced infarct size(19.7%±2.8% in group 3) of the left ventricular area at risk as compared with control group (37.8%±1.7% in group 2). Group 3 had a higher levels of IL-10 than that of Group 2. Conclusion: Isoflurane can promote Bcl-2 expression and increase the IL-10 level during ischemia reperfusion, which may be one of molecular mechanisms of isoflurane delayed preconditioning on cardioprotection.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the protective effect of isoflurane delayed preconditioning on myocardial ischemia reperfusion injury and the potential mechanisms in rabbit. Methods:Thirty New Zealand male white rabbits were randomly assigned to 3 groups:(1)Control group;(2)I/R group;(3)2.0% isoflurane group. Group 3 was exposed to 2.0% isoflurane-100% oxygen for 2 h. Group 1 and group 2 were exposed 2 h to 100% oxygen serving as untreated controls. Twenty-four hours later group 2 and group 3 underwent 40 min of coronary occlusion followed by 2 h of reperfusion. Blood samples were taken from arterial line at 20min before occlusion(T1)、20min after occlusion(T2)、40min after occlusion(T3)、1h after reperfusion(T4) and 2h after reperfusion(T5) for determination of the plasma level of IL-10. At the end of the reperfusion, infarct size(IS) and area at risk(AAR) were defined by Evans and TTC staining. The heart was harvested and level of the Bcl-2 expression was determined by Western Blot analysis. Results: The Bcl-2 level of group 3 was significantly higher than that of group 2(P0.05). Isoflurane significantly(P0.05) reduced infarct size(19.7%±2.8% in group 3) of the left ventricular area at risk as compared with control group (37.8%±1.7% in group 2). Group 3 had a higher levels of IL-10 than that of Group 2. Conclusion: Isoflurane can promote Bcl-2 expression and increase the IL-10 level during ischemia reperfusion, which may be one of molecular mechanisms of isoflurane delayed preconditioning on cardioprotection.

Key concepts: Isoflurane, Medicine, Coronary occlusion, Anesthesia, Occlusion, Ischemia, Reperfusion injury, Ischemic preconditioning

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of isoflurane delayed preconditioning on Bcl-2 protein expression and IL-10 level in ischemiareperfusion myocardium of rabbit — Research Paper | ScholarLens